N-Acetylcysteine in the Management of Spontaneous Bacterial Peritonitis | MicrobiomeTrials← Back to trialsNCT07803952
N-Acetylcysteine in the Management of Spontaneous Bacterial Peritonitis
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-10Est. Completion: 2027-09-01
Enrollment target: 60 participants Other microbiome trials you might be interested in
SBP - Spontaneous Bacterial Peritonitis
Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis characterized by infection…
Multiple LocationsEst. completion Sep 1, 2027
Diabetes MellitusHepatitis C, ChronicCardiovascular Diseases
Background:
Chronic hepatitis C infects the liver. It may scar the liver. This is called cirrhosis and may lead to live…
Bethesda, United StatesEst. completion Dec 31, 2032